An open-label, single-arm, phase 2 trial of the polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer

Walter M. Stadler, David J. Vaughn, Guru Sonpavde, Nicholas J. Vogelzang, Scott T. Tagawa, Daniel P. Petrylak, Peter Rosen, Chia Chi Lin, John Mahoney, Sanjiv Modi, Peter Lee, Marc S. Ernstoff, Wu Chou Su, Alexander Spira, Korinna Pilz, Richard Vinisko, Charles Schloss, Holger Fritsch, Charles Zhao, Michael A. Carducci

Research output: Contribution to journal › Article › peer-review

65 Scopus citations

Fingerprint

Dive into the research topics of 'An open-label, single-arm, phase 2 trial of the polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences